title: Treatment of social phobia with drugs other than benzodiazepines.
abstract: Social phobia is emerging as an important cause of psychiatric morbidity. Reasons for this are described, as are clinical issues of importance to social phobia, including the extensive associated distress and disability. The use of phenelzine, atenolol, buspirone, fluoxetine, and moclobemide are described. Diagnostic and transcultural aspects of social phobia are described.
authors.affiliation: Anxiety Disorders Clinic, New York State Psychiatric Institute, N.Y. 10032.
authors.forename: M R
authors.initials: MR
authors.lastname: Liebowitz
authors.forename: F R
authors.initials: FR
authors.lastname: Schneier
authors.forename: E
authors.initials: E
authors.lastname: Hollander
authors.forename: L A
authors.initials: LA
authors.lastname: Welkowitz
authors.forename: J B
authors.initials: JB
authors.lastname: Saoud
authors.forename: J
authors.initials: J
authors.lastname: Feerick
authors.forename: R
authors.initials: R
authors.lastname: Campeas
authors.forename: B A
authors.initials: BA
authors.lastname: Fallon
authors.forename: L
authors.initials: L
authors.lastname: Street
authors.forename: A
authors.initials: A
authors.lastname: Gitow
mesh_terms: D000293:Adolescent; D001262:Atenolol / Q000627:therapeutic use; D001549:Benzamides / Q000627:therapeutic use; D002065:Buspirone / Q000627:therapeutic use; D002648:Child; D002986:Clinical Trials as Topic; D005260:Female; D005473:Fluoxetine / Q000627:therapeutic use; D006801:Humans; D008297:Male; D020912:Moclobemide; D010624:Phenelzine / Q000627:therapeutic use; D010698:Phobic Disorders / Q000175:diagnosis / Q000188:drug therapy* / Q000523:psychology; D010919:Placebos
chemical_list: D001549:Benzamides; D010919:Placebos; D005473:Fluoxetine; D001262:Atenolol; D010624:Phenelzine; D020912:Moclobemide; D002065:Buspirone